RxDoctor Payments Data

Melanie Pistentis, PA

Medical · Latrobe, PANPI 1932487808

Payments from drug & device makers

$2,218in general payments, 2019–2025

Across 142 payments — averaging $15.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$436
  • Johnson & Johnson$335
  • Astellas Pharma US Inc$333
  • Myovant Sciences Inc.$270
  • Pfizer$174
  • Myriad Genetic Laboratories, Inc.$110
  • plus $561 from 12 others

What the payments were for

  • Food & beverage$2,15797%
  • Education$613%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,218 in reported general payments places this provider in the 80th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$17,453
Medicare patients
192
Services billed
239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron122$93,607
GemtesaVibegron23$15,179
ElmironPentosan Polysulfate Sodium12$11,933
Mirabegron ErMirabegron16$8,131
Tamsulosin Hcl450$7,798
Methenamine Hippurate38$4,893
Trospium Chloride ErTrospium Chloride27$4,025
Solifenacin Succinate139$3,920
Finasteride223$3,290
Tolterodine Tartrate ErTolterodine Tartrate31$3,149
Estradiol27$2,640
Oxybutynin Chloride ErOxybutynin Chloride95$2,535
Dutasteride28$1,629
Desmopressin Acetate14$1,364
Trimethoprim16$1,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$333$93,607122 claims
Sumitomo Pharma America, Inc.Gemtesa$436$15,17923 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Latrobe

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →